10-Q: Vynleads Reports Continued Losses, Faces Going Concern Doubt

Vynleads, Inc. filed its Form 10-Q for the period ended June 30, 2026, revealing persistent operating losses, a growing accumulated deficit, and significant concerns about its ability to continue as a going concern.

Summary

• Vynleads, Inc. reported no revenue for the three and six months ended June 30, 2026, and June 30, 2025.
• Total costs and operating expenses increased by 15% to $156,439 for the six months ended June 30, 2026, compared to $136,164 for the same period in 2025, primarily due to the use of a third-party software development team.
• Selling, general, and administrative expenses rose by 19% to $151,425 for the six months ended June 30, 2026, compared to $127,720 in the prior year.
• The net loss for the six months ended June 30, 2026, was $160,845, an increase from $138,051 in the same period of 2025.
• As of June 30, 2026, the company had a working capital deficit of $448,276 and an accumulated deficit of $3,201,441, raising substantial doubt about its ability to continue as a going concern.
• The company estimates it requires approximately $5,500,000 in additional working capital over the next 12 months to fund operations, product development, and marketing.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as highly negative due to the company's continued operating losses, negative cash flow, and substantial doubt about its ability to continue as a going concern, despite efforts to secure additional capital.

Positives

• The company's disclosure controls and procedures were deemed effective at a reasonable assurance level as of June 30, 2026.
• Mr. Mannine, the CEO, has voluntarily waived cash compensation since September 21, 2020, contributing his services in-kind.

Negatives

• No revenue was generated in the reported periods.
• The company incurred a net loss of $160,845 for the six months ended June 30, 2026, an increase from the prior year.
• A significant working capital deficit of $448,276 exists as of June 30, 2026.
• The accumulated deficit has grown to $3,201,441 as of June 30, 2026.
• Two notes payable, totaling $75,000, are currently in default.
• The company has no committed financing sources or unused financing facilities.
• The company requires an estimated $5,500,000 in additional working capital within the next 12 months, with no assurance of securing these funds.

Risks

• Substantial doubt exists regarding the company's ability to continue as a going concern due to recurring operating losses, negative cash flows, and a significant working capital deficit.
• Failure to secure an estimated $5,500,000 in additional working capital within the next 12 months could force the company to curtail or discontinue operations.
• The company relies on a single supplier for its herbal/natural supplements inventory, posing a risk of supply interruption and material business impact.
• Two notes payable, totaling $75,000, are currently in default, which could lead to further financial distress.
• The company's strategic objective to expand into new areas and market its services is dependent on its ability to generate sufficient revenues and secure additional capital.

Future Outlook

The company requires approximately $5,500,000 in additional working capital over the next 12 months to fund business objectives, including product development, marketing, infrastructure expansion, and operating expenses. There is no assurance that this capital will be secured, and failure to do so could adversely impact revenue and operations, potentially jeopardizing the company's ability to continue as a going concern.

Management Comments

• Management believes that there is substantial doubt about our ability to continue as a going concern.
• Our ability to meet our current and projected obligations depends on our ability to generate sufficient sales and to control expenses and will require that we seek additional capital through private and/or public financing sources.
• There can be no assurances that we will achieve our forecasted financial results or that we will be able to raise additional capital to operate our business.
• Any such failure would have a material adverse impact on our liquidity and financial condition and could force us to curtail or discontinue operations entirely and could require us to file for protection under bankruptcy laws.

Industry Context

StockSavvy.ai notes that Vynleads operates in the wellness technology sector, focusing on metabolic health and chronic conditions. While the market for digital health solutions, particularly those leveraging AI for personalized wellness, is growing, Vynleads' current financial performance indicates significant challenges in scaling its operations and achieving profitability within this competitive landscape.

Comparison to Industry Standards

• Companies in the digital health and wellness technology sector often demonstrate significant revenue growth, even in early stages, which Vynleads has not achieved, reporting $0 revenue for the periods presented.
• Established players in chronic disease management, such as Livongo (now part of Teladoc Health) or Omada Health, have demonstrated ability to scale through B2B partnerships with health plans and employers, generating substantial revenue and achieving profitability, a stage Vynleads has yet to reach.
• The average burn rate for venture-backed health tech startups can be high, but typically correlates with significant revenue generation or clear pathways to it; Vynleads' high operating expenses relative to its lack of revenue is a key concern.
• Industry benchmarks for companies at Vynleads' stage often involve securing substantial Series A or B funding rounds to fuel growth, which Vynleads has not indicated it is close to achieving.

Legal Proceedings

• The company is disputing claims from a former consultant regarding promotional services and royalty payments, and is pursuing the removal of unauthorized UCC liens filed against the company and its officers/directors.

Related Party Transactions

• Mr. Mannine, the CEO, voluntarily waived all cash compensation due under his employment agreement since September 21, 2020, with $32,500 recorded as an in-kind contribution of services for the six months ended June 30, 2026 and 2025.

Stakeholder Impact

• Shareholders face significant risk of losing their entire investment if the company cannot secure additional capital and continue as a going concern.
• Employees may face uncertainty regarding job security due to the company's precarious financial situation.
• Suppliers, particularly the single supplier for herbal/natural supplements, face potential disruption if the company ceases operations.
• Creditors, especially holders of the defaulted notes payable, face a high risk of non-payment.

Next Steps

• Seek additional capital through private and/or public financing sources.
• Expand service and product offerings into additional areas.
• Market and promote services and product offerings.
• Develop and grow infrastructure and corporate organization.
• Continue to develop new indicators for the Lifestyle Blueprint platform.
• Add print versions of the DWD Protocol.
• Expand the supplement product line.
• Offer additional subscription content.

Key Dates

Recommendation

The filing indicates a severe going concern issue with no revenue, increasing losses, and a substantial capital requirement that lacks any committed funding. The company is in default on multiple notes payable. These factors present an extremely high risk to investors, making a sell recommendation appropriate.

Keywords

wellness technology, metabolic health, type 2 diabetes, prediabetes, lifestyle program, digital platform, AI coach, financial condition